West Pharmaceutical Services WST Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's free cash flow?
- West Pharmaceutical Services (WST) reported free cash flow of $47.2M in Q1 2026.
- How has West Pharmaceutical Services's free cash flow changed year-over-year?
- West Pharmaceutical Services's free cash flow decreased by 18.8% year-over-year, from $58.1M to $47.2M.
- What is the long-term trend for West Pharmaceutical Services's free cash flow?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's free cash flow has grown at a 9.1% compound annual growth rate (CAGR), from $330.6M to $468.9M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.